The failure of anxiolytic therapies in early clinical trials: what needs to be done.
about
Don't stress about CRF: assessing the translational failures of CRF1antagonists.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
P2860
The failure of anxiolytic therapies in early clinical trials: what needs to be done.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The failure of anxiolytic therapies in early clinical trials: what needs to be done.
@en
type
label
The failure of anxiolytic therapies in early clinical trials: what needs to be done.
@en
prefLabel
The failure of anxiolytic therapies in early clinical trials: what needs to be done.
@en
P2093
P2860
P1476
The failure of anxiolytic therapies in early clinical trials: what needs to be done.
@en
P2093
Adam Michael Stewart
Allan V Kalueff
David J Echevarria
Jason E Warnick
Manoj K Poudel
P2860
P304
P356
10.1517/13543784.2015.1019063
P407
P577
2015-03-01T00:00:00Z